2024-01-04 16:51:37 ET
DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- Dermata Therapeutics, Inc. (NASDAQ: DRMA) announced, after today’s market close, that it was issued a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis, entitled “Compositions for the treatment of skin conditions” (Japanese Patent No. 7395576), which further strengthens Dermata’s intellectual property for DMT410 for the treatment of hyperhidrosis and could lead to further protections for additional indications. Furthermore, Dermata is currently discussing partnership opportunities to advance development of DMT410.
Omega Therapeutics is trading at $1.14, up $0.53 (+86.89%), on 5.4M shares traded.
Its 52-week range is $0.5359 to $5.624. This set a new 52-week price low, just last week, and it already hit an afterhours trading high …
The post Japanese Patent Issuance Expands This Listing’s Global Intellectual Patent Portfolio appeared first on 24/7 Market News .
For further details see:
Japanese Patent Issuance Expands This Listing’s Global Intellectual Patent Portfolio